Epidemiology of gestational trophoblastic disease - PubMed (original) (raw)

Review

Epidemiology of gestational trophoblastic disease

D A Grimes. Am J Obstet Gynecol. 1984.

Abstract

The epidemiology of gestational trophoblastic disease is not well understood. Methodologic problems with published reports limit the interpretation of incidence data, although the frequency of hydatidiform mole appears to be about one per 1000 pregnancies. No consistent temporal trends in rates of either hydatidiform mole or choriocarcinoma are evident. Hydatidiform mole appears to be caused by abnormal gametogenesis and fertilization. Age, ethnicity, and a history of hydatidiform mole appear to be important risk factors for hydatidiform mole. Age, ethnicity, a history of hydatidiform mole or fetal wastage, and ABO blood group interactions appear to be important risk factors for choriocarcinoma. Future studies should focus on the mechanisms by which these risk factors influence gametogenesis, fertilization, and malignant transformation of trophoblastic tissue.

PubMed Disclaimer

Cited by

Mortality factors in high and ultra-high-risk gestational trophoblastic neoplasia at moi teaching & referral hospital: A decade-long observation in kenya.
Hassan AR, Itsura PM, Rosen BP, Covens AL, Shaffi AF, Odongo EB, Mburu AW, Smith WL, Moturi SK, Too RK, Ayeah CM, Tonui PK. Hassan AR, et al. Gynecol Oncol Rep. 2024 Apr 16;53:101392. doi: 10.1016/j.gore.2024.101392. eCollection 2024 Jun. Gynecol Oncol Rep. 2024. PMID: 38694708 Free PMC article.
High Incidence of Gestational Trophoblastic Disease in a Third-Level University-Hospital, Italy: A Retrospective Cohort Study.
Capobianco G, Tinacci E, Saderi L, Dessole F, Petrillo M, Madonia M, Virdis G, Olivari A, Santeufemia DA, Cossu A, Dessole S, Sotgiu G, Cherchi PL. Capobianco G, et al. Front Oncol. 2021 May 5;11:684700. doi: 10.3389/fonc.2021.684700. eCollection 2021. Front Oncol. 2021. PMID: 34026657 Free PMC article.
Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypes.
Khawajkie Y, Mechtouf N, Nguyen NMP, Rahimi K, Breguet M, Arseneau J, Ronnett BM, Hoffner L, Lazure F, Arnaud M, Peers F, Tan L, Rafea BA, Aguinaga M, Horowitz NS, Ao A, Tan SL, Brown R, Buckett W, Surti U, Hovanes K, Sahoo T, Sauthier P, Slim R. Khawajkie Y, et al. Mod Pathol. 2020 May;33(5):880-892. doi: 10.1038/s41379-019-0432-4. Epub 2019 Dec 19. Mod Pathol. 2020. PMID: 31857680
Expression patterns of maspin and mutant p53 are associated with the development of gestational trophoblastic neoplasia.
Sun P, Wu Q, Ruan G, Zheng X, Song Y, Zhun J, Wu L, Gotlieb WH. Sun P, et al. Oncol Lett. 2016 Nov;12(5):3135-3142. doi: 10.3892/ol.2016.5074. Epub 2016 Sep 1. Oncol Lett. 2016. PMID: 27899973 Free PMC article.
Two novel mutations in the KHDC3L gene in Asian patients with recurrent hydatidiform mole.
Rezaei M, Nguyen NM, Foroughinia L, Dash P, Ahmadpour F, Verma IC, Slim R, Fardaei M. Rezaei M, et al. Hum Genome Var. 2016 Sep 1;3:16027. doi: 10.1038/hgv.2016.27. eCollection 2016. Hum Genome Var. 2016. PMID: 27621838 Free PMC article.

Epidemiology of gestational trophoblastic disease - PubMed (original) (raw)